ENALAPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12.5 mg, scored tablet 84 tablets
Active ingredients: HYDROCHLOROTHIAZIDE, Enalapril maleate
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet84 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENALAPRIL/HYDROCHLOROTHIAZIDE ZENTIVA 20 mg/12,5 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC de 84 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68355755CIP73742156CIP133400937421560Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 12,5 mg · un comprimé | SA |
| MALÉATE D'ÉNALAPRILcomprimé | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.